BNP Paribas Financial Markets’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
3
| – | – | ﹤0.01% | 4615 |
|
|
2025
Q1 | $3 | Hold |
3
| – | – | ﹤0.01% | 4527 |
|
|
2024
Q4 | $3 | Buy |
+3
| New | +$3 | ﹤0.01% | 4530 |
|
|
2022
Q4 | – | Sell |
-7
| Closed | -$29 | – | 3891 |
|
|
2022
Q3 | $29 | Hold |
7
| – | – | ﹤0.01% | 3972 |
|
|
2022
Q2 | $42 | Hold |
7
| – | – | ﹤0.01% | 3400 |
|
|
2022
Q1 | $83 | Sell |
7
-41
| -85% | -$486 | ﹤0.01% | 3526 |
|
|
2021
Q4 | $704 | Buy |
48
+39
| +433% | +$572 | ﹤0.01% | 3432 |
|
|
2021
Q3 | $264 | Sell |
9
-21
| -70% | -$616 | ﹤0.01% | 3341 |
|
|
2021
Q2 | $1.38K | Sell |
30
-425
| -93% | -$19.5K | ﹤0.01% | 3318 |
|
|
2021
Q1 | $27.3K | Sell |
455
-200
| -31% | -$12K | ﹤0.01% | 3145 |
|
|
2020
Q4 | $34.3K | Sell |
655
-138
| -17% | -$7.23K | ﹤0.01% | 3051 |
|
|
2020
Q3 | $27.4K | Buy |
793
+672
| +555% | +$23.2K | ﹤0.01% | 3097 |
|
|
2020
Q2 | $10.5K | Sell |
121
-766
| -86% | -$66.5K | ﹤0.01% | 3056 |
|
|
2020
Q1 | $51.5K | Buy |
887
+550
| +163% | +$31.9K | ﹤0.01% | 2916 |
|
|
2019
Q4 | $24.3K | Sell |
337
-72
| -18% | -$5.19K | ﹤0.01% | 3275 |
|
|
2019
Q3 | $24.9K | Buy |
409
+130
| +47% | +$7.92K | ﹤0.01% | 3210 |
|
|
2019
Q2 | $26.5K | Sell |
279
-257
| -48% | -$24.4K | ﹤0.01% | 3170 |
|
|
2019
Q1 | $43.4K | Buy |
536
+527
| +5,856% | +$42.7K | ﹤0.01% | 2995 |
|
|
2018
Q4 | $1.46K | Sell |
9
-8
| -47% | -$1.3K | ﹤0.01% | 3180 |
|
|
2018
Q3 | $2.69K | Buy |
+17
| New | +$2.69K | ﹤0.01% | 3546 |
|